Timothy Miller
Physician · Select Medical
Credentials: · · ·
History
- 2026–Present
Research
Unraveling the mechanisms involved in motor neuron degeneration in ALS
Review · Annual Review of Neuroscience · 2004 · 1,081 citations
Distinct tau prion strains propagate in cells and mice and define different tauopathies
Neuron · 2014 · 810 citations
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
New England Journal of Medicine · 2022 · First of 27 authors · 755 citations
24 papers
22 papers
18 papers
18 papers
18 papers
- NM
17 papers
16 papers
14 papers · 2 as a fellow
Grants
- 2026–2028
Evaluating iPSC-Derived Models to Study and Treat Mitchell Syndrome
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $427.6K · Washington University
- 2024–2026
Directly Converted Neurons as a Novel Cellular Model for ALS and FTD
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $427.6K · Washington University
- 2012–2022
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $3.9M · Washington University
- 2016–2021
Understanding SOD1 Kinetics in Amyotrophic Lateral Sclerosis
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.7M · Washington University
Clinical trials
- 2019–2022
Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis
Principal investigator · Completed · Phase 1
Washington University School of Medicine
- 2015–2018
Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS
Principal investigator · Completed
Washington University School of Medicine
- 2010–2012
Study chair · Completed · Phase 1
Ionis Pharmaceuticals, Inc.